Abstract
Background: Cigarette smoking remains the single largest cause of premature death in the United Kingdom. As part of the government's national service framework for coronary heart disease, smoking cessation forms a key part of the strategy.
Objectives: To determine the effectiveness of bupropion treatment for smoking cessation in a general practice setting, measuring continuous abstinence from smoking, from 8 weeks to 52 weeks.
Design: Prospective observational study.
Setting: One general practice (six whole time equivalent doctors, 11 070 patients) in rural Northumberland.
Subjects: Of the 243 patients who presented to the practice over a one year period for smoking cessation, a total of 227 motivated people, who were appropriate for bupropion treatment as a pharmacological aid for smoking cessation, entered the study. Continuous smoking cessation at one year was validated by an exhaled carbon monoxide level of 10 ppm or less.
Results: Fifty patients successfully gave up smoking, giving a one year smoking cessation prevalence with bupropion of 22% (95% confidence intervals (CI) 17% to 28%). There was no difference in success rate for sex, number of cigarettes smoked, the number of years smoking, or whether there were other smokers in the household or not.
Conclusion: Bupropion treatment in this general practice helped 22% of motivated people to quit and remain stopped smoking at one year. Mainly nurses, whose prescribing rights are restricted and currently exclude bupropion, deliver smoking cessation services in primary care.
Full Text
The Full Text of this article is available as a PDF (67.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aubin H. J., Lebargy F., Berlin I., Bidaut-Mazel C., Chemali-Hudry J., Lagrue G. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial. Addiction. 2004 Sep;99(9):1206–1218. doi: 10.1111/j.1360-0443.2004.00814.x. [DOI] [PubMed] [Google Scholar]
- Austoker J., Sanders D., Fowler G. Smoking and cancer: smoking cessation. BMJ. 1994 Jun 4;308(6942):1478–1482. doi: 10.1136/bmj.308.6942.1478. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. Imperial Cancer Research Fund OXCHECK Study Group. BMJ. 1995 Apr 29;310(6987):1099–1104. [PMC free article] [PubMed] [Google Scholar]
- Holmes S., Zwar N., Jiménez-Ruiz C. A., Ryan P. J., Browning D., Bergmann L., Johnston J. A. Bupropion as an aid to smoking cessation: a review of real-life effectiveness. Int J Clin Pract. 2004 Mar;58(3):285–291. doi: 10.1111/j.1368-5031.2004.00153.x. [DOI] [PubMed] [Google Scholar]
- Hurt R. D., Sachs D. P., Glover E. D., Offord K. P., Johnston J. A., Dale L. C., Khayrallah M. A., Schroeder D. R., Glover P. N., Sullivan C. R. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med. 1997 Oct 23;337(17):1195–1202. doi: 10.1056/NEJM199710233371703. [DOI] [PubMed] [Google Scholar]
- Jorenby D. E., Leischow S. J., Nides M. A., Rennard S. I., Johnston J. A., Hughes A. R., Smith S. S., Muramoto M. L., Daughton D. M., Doan K. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med. 1999 Mar 4;340(9):685–691. doi: 10.1056/NEJM199903043400903. [DOI] [PubMed] [Google Scholar]
- Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study. Family Heart Study Group. BMJ. 1994 Jan 29;308(6924):313–320. [PMC free article] [PubMed] [Google Scholar]
- Raw M., McNeill A., West R. Smoking cessation guidelines for health professionals. A guide to effective smoking cessation interventions for the health care system. Health Education Authority. Thorax. 1998 Dec;53 (Suppl 5 Pt 1):S1–19. doi: 10.1136/thx.53.2008.s1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Swan Gary E., McAfee Tim, Curry Susan J., Jack Lisa M., Javitz Harold, Dacey Sara, Bergman Katherine. Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial. Arch Intern Med. 2003 Oct 27;163(19):2337–2344. doi: 10.1001/archinte.163.19.2337. [DOI] [PubMed] [Google Scholar]
- Tønnesen P., Tonstad S., Hjalmarson A., Lebargy F., Van Spiegel P. I., Hider A., Sweet R., Townsend J. A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation. J Intern Med. 2003 Aug;254(2):184–192. doi: 10.1046/j.1365-2796.2003.01185.x. [DOI] [PubMed] [Google Scholar]
- West R., McNeill A., Raw M. Smoking cessation guidelines for health professionals: an update. Health Education Authority. Thorax. 2000 Dec;55(12):987–999. doi: 10.1136/thorax.55.12.987. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Woolacott N. F., Jones L., Forbes C. A., Mather L. C., Sowden A. J., Song F. J., Raftery J. P., Aveyard P. N., Hyde C. J., Barton P. M. The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation. Health Technol Assess. 2002;6(16):1–245. doi: 10.3310/hta6160. [DOI] [PubMed] [Google Scholar]